Zhejiang Hengtong Stock Hits Day Low of CNY 4.77 Amid Price Pressure

Zhejiang Hengtong Holding Co., a prominent player in the Pharmaceuticals & Biotechnology sector, experienced a significant decline today, with its stock price dropping by 6.65% as of March 20, 2026. The stock reached an intraday low of CNY 4.77, reflecting a challenging trading environment. Over the past week, the company's performance has been notably weak, with a decrease of 14.52%, compared to a 3.38% decline in the China Shanghai Composite index. The one-month performance shows a more pronounced drop of 21.29%, while year-to-date figures indicate a decline of 10.51%. Despite these short-term challenges, the stock has shown resilience over the longer term, boasting a 67.37% increase over the past year. Key financial metrics reveal a debt-equity ratio of 0.09, indicating a relatively low level of debt, while the return on equity stands at 5.60%. The company's price-to-book ratio is 5.22, suggesting a premium valuation in the market. As Zhejiang Hengtong navigates these fluctuations, its performance metrics will be closely monitored by market participants.